Table 3.
Multivariate analyses for overall survival, PSA-FFS, Grade ≥2 late GU and GI toxicity
Overall survival | PSA-FFS | Late GU toxicity | Late GI toxicity | |||||
---|---|---|---|---|---|---|---|---|
Hazard ratio | P | Hazard ratio | P | Hazard ratio | P | Hazard ratio | P | |
Age | 2.73 | 0.02 | 0.89 | 0.68 | 1.90 | 0.17 | 1.27 | 0.49 |
(≥ vs <70 years) | (1.19–6.27) | (0.50–1.57) | (1.77–4.71) | (0.65–2.50) | ||||
Risk | 1.62 | 0.26 | 2.66 | 0.005 | 1.09 | 0.86 | 1.15 | 0.71 |
(HR vs LR/IR) | (0.70–3.72) | (1.35–5.22) | (0.43–2.70) | (0.56–2.34) | ||||
ADT | 3.22 | 0.13 | 1.12 | 0.81 | 1.32 | 0.72 | 4.33 | 0.15 |
(Yes vs no) | (0.71–14.51) | (0.43–2.96) | (0.30–5.81) | (0.59–32.00) | ||||
Anticoagulant | 1.66 | 0.23 | 0.51 | 0.13 | 1.62 | 0.33 | 2.03 | 0.06 |
(Yes vs no) | (0.73–3.81) | (0.21–1.22) | (0.61–4.26) | (0.97–4.24) | ||||
Coexistent DM | 0.86 | 0.76 | 1.43 | 0.32 | 1.42 | 0.49 | 1.71 | 0.17 |
(Yes vs no) | (0.32–2.29) | (0.71–2.90) | (0.52–3.92) | (0.80–3.66) |
LR, IR, HR = low, intermediate, and high risk, ADT = androgen deprivation therapy, DM = diabetes mellitus.